ACGT Awards Luncheon Honors Crystal Mackall, MD, With Edward Netter Leadership Award
Alliance for Cancer Gene Therapy (ACGT) awarded The Edward Netter Leadership Award to Crystal Mackall, MD, of Stanford University.
Alliance for Cancer Gene Therapy (ACGT) awarded The Edward Netter Leadership Award to
The ACGT Awards Luncheon celebrated the non-profit organization’s 20th anniversary and ushered in a new decade. The event was held during the intermission of the ACGT Summit 2023.
Attendees, including scientists and donors, helped ACGT recognize Dr. Mackall for her incredible achievements, such as the numerous groundbreaking clinical trials she has led to treat children with sarcomas and brain cancers. Named for ACGT co-founder, Edward Netter, the award recognizes a researcher who has made unparalleled and groundbreaking contributions to the field of cell and gene therapy for cancer.
“Without the donors, Alliance for Cancer Gene Therapy doesn’t exist,” Dr. Mackall said, later adding that “you get (a foundation like ACGT) by having a leadership with great instincts, leadership that is passionate, and leadership that has grit.”
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Related Articles
- Around the Helix: Cell and Gene Therapy Company Updates – September 17, 2025
September 17th 2025
- ImmunoLogic, Episode 6: "The Future of Personalized Cancer Vaccines”
September 15th 2025
- Top News in Lymphoma Cell Therapy for World Lymphoma Awareness Day 2025
September 15th 2025